RxNorm Semantic Concepts Index - 475
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "475".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 475 | Substance with aldosterone receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 475 | Substance with aldosterone receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 475 | Substance with aldosterone receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 475 | Substance with aldosterone receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 475 | Substance with aldosterone receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 475230 | degarelix | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 475230 | degarelix | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 475230 | degarelix | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 475230 | degarelix | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 475230 | degarelix | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 475342 | dasatinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 475342 | dasatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 475342 | dasatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 475342 | dasatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 475342 | dasatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 475357 | Angeliq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 47568 | C8 binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47568 | C8 binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47568 | C8 binding protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47568 | C8 binding protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47568 | C8 binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47579 | cabergoline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 47579 | cabergoline | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 47579 | cabergoline | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 47579 | cabergoline | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 47579 | cabergoline | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 47589 | cafedrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 475968 | liraglutide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 475968 | liraglutide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 475968 | liraglutide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 475968 | liraglutide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 475968 | liraglutide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 475969 | etravirine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 475969 | etravirine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 475969 | etravirine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 475969 | etravirine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 475969 | etravirine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 47599 | Calcibind | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 475993 | Amyloid protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 475993 | Amyloid protein | Full form of descriptor (FN) | NO |